DMPHF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dermapharm Holding SE

Watchlist Manager

Watchlist

Price: 47.69 USD -10.02% Market Closed

Market Cap: $2.6B

	Dermapharm Holding SE OTC:DMPHF	DE
	Indian Metals and Ferro Alloys Ltd NSE:IMFA	IN
V	Vesuvius PLC SWB:V4S	UK
	DWS Group GmbH & Co KgaA F:DWS	DE
E	E ON SE PSE:EOAN	DE
	Sberbank Rossii PAO MOEX:SBERP	RU
P	Petroleo Brasileiro SA Petrobras MAD:XPBRA	BR
G	Genesis AI Corp OTC:AIGFF	CA
	Hulic Co Ltd TSE:3003	JP
	Societe de Services de Participations, de Direction et d'Elaboration SA F:YX5	BE
5	5E Advanced Materials Inc NASDAQ:FEAM	US
M	MorphoSys AG XHAM:MOR	DE
	Telenor ASA F:TEQ	NO

Profitability Summary

Dermapharm Holding SE's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

65%

Gross Margin is Increasing

64% > 68%

Healthy Operating Margin

20%

Sustainable 3Y Average Operating Margin

19%

Declining Operating Margin

22% > 20%

Healthy Net Margin

12%

Low 3Y Average Net Margin

Net Margin is Increasing

11% > 12%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

16%

Declining Free Cash Flow Margin

23% > 21%

Positive ROE

21%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.